Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Heart Valve Diseases

moxifloxacin has been researched along with Heart Valve Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Algaidi, SH; Alghamdi, DI; Algheffari, SG; Alzahrani, RA; Hafiz, AM; Thabit, AK1
Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Pefanis, A; Sakka, V; Skiadas, I; Triantafyllidi, H1
Lee, WC; Yew, KL1
Athanasopoulos, G; Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Pefanis, A; Sakka, V1

Other Studies

4 other study(ies) available for moxifloxacin and Heart Valve Diseases

ArticleYear
Long-term Cardiovascular Adverse Events Induced by Fluoroquinolones: A Retrospective Case-control Study.
    Journal of cardiovascular pharmacology, 2023, Nov-01, Volume: 82, Issue:5

    Topics: Case-Control Studies; Ciprofloxacin; Fluoroquinolones; Heart Valve Diseases; Humans; Levofloxacin; Moxifloxacin; Retrospective Studies

2023
Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Aza Compounds; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Moxifloxacin-warfarin interaction.
    The Medical journal of Malaysia, 2012, Volume: 67, Issue:4

    Topics: Anti-Infective Agents; Anticoagulants; Aza Compounds; Drug Interactions; Female; Fluoroquinolones; Heart Valve Diseases; Humans; International Normalized Ratio; Middle Aged; Mitral Valve; Moxifloxacin; Quinolines; Tricuspid Valve; Warfarin

2012
Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aortic Valve; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Moxifloxacin; Quinolines; Rabbits; Streptococcal Infections; Streptococcus oralis

2005